The Food and Drug Administration (FDA) has approved a new drug for treating urinary tract infections, the first such drug ...

The role of the Gastrointestinal Drugs Advisory Committee (GIDAC) is to review and evaluate available data ‘concerning the safety and effectiveness of marketed and investigational human drug ...

Researchers have developed a new type of oral painkiller for chronic abdominal pain, inspired by the peptide hormone oxytocin ...

Magnesium is essential for muscle, nerve function, blood sugar control, and energy production. Deficiency symptoms can be ...

Probiotics are live microorganisms that may offer certain health benefits, including possible relief of acid reflux symptoms.

People with inflammatory bowel disease (IBD) or Parkinson’s disease have depletions in similar types of beneficial bacteria, ...

Intracavitary tumors, including those originating from the respiratory tract, gastrointestinal (GI) tract, and urinary tract, mainly consist of epithelial cancers sharing similar characteristics, such ...

An estimated 20% of Americans suffer from GERD, a chronic form of acid reflux that goes beyond occasional heartburn. Here's ...

Weight loss is a key effect of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), but these drugs may also provide liver ...

Researchers suggest the 20% reduction in nonfatal heart attacks was the primary driver of this benefit for patients with type ...

Cabozantinib, an oral tyrosine kinase inhibitor, has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of patients with previously treated advanced neuroendocrine tumors ...

Incremental cardiometabolic risk factors — particularly diabetes, hypertension and high waist circumstance — were linked to ...